2 November 2018 - - US-based digital health company Klue, which is focused on behaviour tracking and positive change, has expanded its platform to Type 1 Diabetes, the company said.

Klue is already known for its gesture sensing and analytics technology that promotes mindful eating and proper hydration. Now, it is ready to branch out in diabetes.

Leveraging patented technology to create never-seen-before capabilities in the realm of treating T1D, Klue's software unlocks solutions that will be life-changing for patients who have had a lifetime of daily injections and blood sugar monitoring.

Intuitive and proactive, Klue's fine motor artificial intelligence technology detects high impact moments and allows individuals to better manage their health, all based on insights that are captured automatically and non-intrusively from analyzing their wrist movements.

Klue then coaches and engages users around those "in-the-moment" events, for example by sending them bolus reminders. Klue's early meal detection capabilities and unique insights into eating behaviors are critical components towards the realization of the holy grail; fully autonomous artificial pancreas systems.

With its expansion into the T1D arena, Klue is adding a mealtime medication reminder to its suite of turnkey engagement modules.

The module, specifically designed for individuals with T1D, works seamlessly with hardware such as the Apple Watch.

This module also features automated text messaging, keeping caregivers connected and offering peace of mind for loved ones who are concerned.